Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pretreatment p53 protein expression correlates with decreased survival in patients with end-stage head and neck cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Nov 1995

Sauter E R, Ridge J A, Litwin S, Langer C J

Abstract excerpt

Relatively little is known about p53 changes in far-advanced head and neck cancer for several reasons: (a) most patients respond well to initial treatment; (b) most institutions do not encounter large numbers of these patients; (c) recurrent or metastatic disease is often within body cavities inaccessible for analysis; and (d) the variety of treatment regimens and disease sites makes meaningful conclusions...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Carcinoma, Squamous Cell

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genes, p53

Share to Head and Neck Neoplasms

Share to Mutation

Share to Neoplasm Proteins

Share to Prognosis

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 9815938

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pretreatment p53 protein expression correlates with decreased survival in patients with end-stage head and neck cancer.PMID 9815938Read ↗

Loss of p53 gene mutation after irradiation is associated with increased aggressiveness in recurring head and neck cancer.Semantic proximity Read ↗

Patterns of p53 gene mutations in head and neck cancer: full-length gene sequencing and results of primary radiotherapy.Semantic proximity Read ↗

Expression of p53 protein in advanced head and neck squamous cell carcinoma before and after chemotherapy.Semantic proximity Read ↗

p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma.Semantic proximity Read ↗

p53 mutation, but not p53 overexpression, correlates with survival in head and neck squamous cell carcinoma.Semantic proximity Read ↗

Tumor angiogenesis and p53 mutations: prognosis in head and neck cancer.Semantic proximity Read ↗

p53 Expression and cell proliferation in squamous cell carcinomas of the head and neckSemantic proximity Read ↗

[p53 mutations and HPV infections in squamous epithelial carcinomas of the head-neck region. Long-term follow-up].Semantic proximity Read ↗

Sequencing analysis of RNA and DNA of exons 1 through 11 shows p53 gene alterations to be present in almost 100% of head and neck squamous cell cancers.Semantic proximity Read ↗

Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer.Semantic proximity Read ↗

p53 Mutation status predicts pathological response to chemoradiotherapy in locally advanced esophageal cancer.Semantic proximity Read ↗

Loss of MTBP expression is associated with reduced survival in a biomarker-defined subset of patients with squamous cell carcinoma of the head and neck.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.